Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for Metsera ...

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Pfizer has filed a second lawsuit against Danish pharmaceutical giant Novo Nordisk, accusing the company of deliberately stalling its $9 billion bid for biotech firm Metsera to hinder competition in ...

Pfizer has launched a second lawsuit against Novo Nordisk over its $9 billion bid for biotech company Metsera. Pfizer accuses ...

Health-care companies rose amid deal activity. Kimberly-Clark agreed to buy over-the-counter drug maker Kenvue for more than $40 billion, combining the maker of Huggies diapers with the owner of ...

Pfizer alleges Novo Nordisk is attempting to "catch and kill" Metsera, a company Pfizer was in the process of acquiring, in ...

Metsera's shareholders are scheduled to meet on November 13 to decide on Novo Nordisk's offer of around $8.5 billion, while ...

Novo Nordisk asserts its acquisition of Metsera won't pose antitrust problems as it competes with Pfizer for dominance in the ...

Pfizer Inc. accused Novo Nordisk A/S of trying to stifle competition in the weight-loss market by attempting to acquire obesity startup Metsera Inc., the second lawsuit Pfizer has filed in four days ...

Pfizer files a second lawsuit against Novo Nordisk and Metsera, accusing its rival of blocking a U.S. competitor in the ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. Read more here.